A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma
Autor: | Kate Reed, Edmond J. Breen, Ben R. Herbert, Douglas H. Campbell, Parisa Asvadi, Michael Copeman, Rosanne Dunn, Patricia Walker, Andrew Spencer |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Lymphoproliferative disorders
Cancer microenvironment medicine.drug_class Cancer immunotherapy Myeloma Monoclonal antibody lcsh:RC254-282 Immunoglobulin kappa-Chains Antineoplastic Agents Immunological Antigen MDX-1097 Correspondence medicine Humans Tissue Distribution Multiple myeloma Aged Aged 80 and over Dose-Response Relationship Drug business.industry Antibodies Monoclonal Hematology Middle Aged Prognosis medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Oncology Cancer research Multiple Myeloma business |
Zdroj: | Blood Cancer Journal, Vol 9, Iss 8, Pp 1-5 (2019) Blood Cancer Journal |
ISSN: | 2044-5385 |
DOI: | 10.1038/s41408-019-0217-5 |
Databáze: | OpenAIRE |
Externí odkaz: |